Introduction
============

Heart disease, just after cancer the first in the rank, was the second leading cause of death in recent years in Taiwan. Based on the World Health Organization classification, coronary artery disease (CAD) is the partial or total loss of the vascular supply to the myocardium [@B1].The principal pathogenesis of CAD is coronary artery atherosclerosis, which is a chronic inflammatory disease of the vessel walls of the coronary artery where monocytes and macrophages accumulate during the initial phase of atherosclerosis [@B2]. The risk factors of CAD include conventional and nonconventional factors [@B3], [@B4]. The conventional risk factors include male gender, hypertension, smoking, diabetes mellitus and high serum cholesterol [@B1], [@B4], [@B5]. Coronary artery disease may be determined by specific genetic polymorphic variants, the nonconventional factors, which affect the production of protein involved in the atherosclerotic processes. Adhesion molecules are one of the important markers of endothelial dysfunction [@B6].

The Intercellular adhesion molecule-I (ICAM-1) gene is located on chromosome 19, and includes 7 exons and 6 introns that code a 90-kDa transmembrane glycoprotein. The protein belongs to the immunoglobulin superfamily of adhesion molecules and consists of five extracellular Ig-like domains, a transmembrane domain, and a short cytoplasmic tail [@B7], [@B8]. It mediates adhesion of circulating leukocytes to the blood vessel wall and activated endothelium as well as the transendothelial migration to the vascular intima, which are important pathogeneic processes of atherosclerosis [@B9], [@B10]. ICAM-1 displays an important role in the development of the inflammation reaction, atherosclerosis, and thrombosis [@B11].

Genetic variants in ICAM-1 gene have been shown to regulate the expression level and have been widely studied for possible genetic association with a range of degenerative and inflammatory diseases [@B12]-[@B14]. A common genetic polymorphism of the ICAM-1 gene, rs5498 (A1548G in exon 6) results the substitution of lysine to glutamate (K469E) and has possible functional value in the etiology of atherosclerosis [@B15]. Previous studies have revealed that polymorphic variations in exon 6 (rs5498), exon 2 (rs5491, K56M) or intron 2 (rs281432, C8823G) and in the region between the ICAM-1 and ICAM-4 genes (rs3093030, C-286T) are associated with risks of diabetes mellulitis, metabolic syndrome, systemic lupus erythematosus and cancers [@B13], [@B16]-[@B18]. To date, few studies report the association of ICAM-1 genetic polymorphisms with CAD in Taiwan. Therefore, we conducted a study to investigate the association of the single nucleotide polymorphisms (SNPs) of ICAM-1, rs5491, rs5498, rs281432 and rs3093030) with CAD.

Material and Methods
====================

Subjects
--------

Five hundred and twenty-five unrelated male and female subjects who received elective coronary angiography in Chung Shan Medical University Hospital were recruited between the years 2005 and 2009. The included subjects for doing elective coronary angiography were those who had positive noninvasive tests such as the treadmill test, myocardial perfusion scan, or cardiac computed tomography scan. The exclusion criteria included patient refusal, known cerebrovascular attack history, peripheral arterial disease, and incomplete data. The diagnostic gold standard of CAD was defined as more than 50% stenosis over any segment of the coronary artery by angiography.

The demographic characteristics were recorded, including gender, age, body length, body weight, systolic pressure, diastolic pressure, body mass index, family history and smoking. The clinical characteristics and risk factors were also recorded, including male gender, age \> 65 years, active smoker, hypertension, diabetic mellitus, aspirin use in the past 7 days and hypercholesterolemia. Active smoker were referred to as a person who currently smoked at least one pack of cigarettes/day. Hypertension was defined as systolic and/or diastolic blood pressure above 140/90 mmHg [@B19] or the studied subjects were receiving anti-hypertensive treatment among the study period. The hypercholesterolemia was defined as serum cholesterol levels more than 200 mg/dL [@B20]. The individuals were determined whether they have more than 3 risk factors according to the male gender, age \> 65 years, active smoker, hypertension, diabetic mellitus, hypercholesterolemia etc. Cardiac marker elevation was known as the elevation of the serum cardiac troponin I level. The study was approved by the Institutional Review Board of Chung Shan Medical University Hospital (CSMUH No: CS07095), and informed consents were obtained from all participants.

Blood sample collection and genomic DNA extraction
--------------------------------------------------

In total, 525 blood specimens were collected from the subjects who received elective coronary angiography in Chung Shan Medical University Hospital. Genomic DNA was extracted from EDTA anti-coagulated venous blood using a QIAamp DNA blood mini kit (Qiagen, Valencia, CA, USA) based on the manufacturer\'s protocol. The DNA was dissolved in Tris ethylene buffer (10 mmol/L Tris and 1 mmol/L EDTA; pH 7.8) and then quantified by a measurement of OD260. The final preparation was stored at -20°C and applied as the template in polymerase chain reaction (PCR).

Selection of intercellular adhesion molecule-1 gene polymorphisms
-----------------------------------------------------------------

Over 20 SNPs in the 7-exon region of the ICAM-1 gene have been documented based on the dbSNP database. This study involved the nonsynonymous SNPs rs5491 (K56M in exon 2) and rs5498 (A1548G in exon 6) in the coding sequences as well as rs281432 (C8823G in intron 2) of the gene based on the Chinese HapMap (Han Chinese in Beijing, China) data. Furthermore, another SNP between the ICAM-1 andICAM-4 genes (rs3093030, C-286T) was selected in this study since this SNP affected the production of sICAM-1 in a Chinese population [@B21]. Because rs5498 is in linkage disequilibrium with rs3093030 (R^2^=0.84) based on Chinese HapMap data, the haplotypes of rs5498 and rs3093030 was established and included into analysis.

Single nucleotide polymorphisms by real time-PCR and genotyping
---------------------------------------------------------------

Allelic discrimination of rs5491(K56M), rs5498 (A1548G), rs281432 (C8823G) and rs3093030 (C-286T) was assessed using an ABI StepOne™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA), and analyzed by SDS version 3.0 software (Applied Biosystems) using the TaqMan assay. The 10 μL final volume for each reaction contained 5 μL TaqMan Genotyping Master Mix, 0.25 μL TaqMan probe mix, and 10 ng genomic DNA. Real-time PCR included an initial denaturation step at 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and then 60°C for one minute.

Statistical analysis
--------------------

Hardy-Weinberg equilibrium was used to analyze the genotype distributions of rs3093030, rs5491, rs281432 and rs5498 in the negative CAD group \[degree of freedom (df)=2\]. Student *t* or chi-square tests were used to analyze the association of demographic features and clinical variables with CAD. Chi-square and Fisher exact tests were used to examine the relationships of the frequencies of *ICAM-1*gene SNPs and haplotypes with the incidence of CAD. The multiple comparisons were corrected by Bonferroni test for *p*vaule. Multiple comparisons within 3 genotypes among each SNP and haplotype were adjusted using simple logistic regression model for the calculation of odds ratio (OR) and its 95% confidence interval (95% CI).

Logistic regression model was used to analyze the associations among ICAM1-1SNP, clinical characteristics and CAD for multivariate analysis. A significant difference was defined as a *p* value of less than 0.05. All statistical analyses were performed using SPSS statistical software (version 11.0; SPSS, Inc., Chicago, IL). Statistical analyses including OR and adjusted odds ratio (AOR) and their 95% CIs were calculated by the SPSS, version 12.0 and WinPepi Software, version 10.0.

Results
=======

The demographic features of the studied subjects with and without CAD
---------------------------------------------------------------------

The demographic features of the studied subjects are showed in Table [1](#T1){ref-type="table"}. There were no significant differences in age, body length, body weight, body mass index, systolic blood pressure and diastolic blood pressure between the patients with CAD and those without CAD. Only the gender exerted a significant difference between the male and female groups (*p*=0.004).

The association of clinical and risk variables with CAD
-------------------------------------------------------

The association of clinical characteristics with CAD was summarized in Table [2](#T2){ref-type="table"}. The male gender was found to increase the risk of developing CAD (*p*=0.004; OR: 1.76, 95% CI: 1.18-2.63). Other factors which displayed the significantly elevated risks of CAD included: aspirin use in the past 7 days (*p*=0.001; OR: 1.99, 95% CI: 1.31-3.05), hypertension (*p*\<0.001; OR: 1.99, 95% CI: 1.33 to 2.96), diabetes mellitus (*p*=0.034; OR: 1.49, 95% CI: 1.01-2.21), cardiac troponin I elevation (*p*\<0.001; OR: 2.26, 95% CI: 1.54 to 3.31), severe angina in the recent 24 hours (*p*\<0.001; OR: 1.97, 95% CI: 1.33-2.90) and \> 3 risk factors (*p*=0.017; OR: 1.55, 95% CI: 1.06-2.26) (Table [2](#T2){ref-type="table"}).

The association of ICAM-1polymorphisms with CAD
-----------------------------------------------

The genotypic distributions of *ICAM-1* SNPs in the subjects with CAD and without CAD are summarized in Table [3](#T3){ref-type="table"}. The genotypic frequency of *ICAM-1* SNP rs281432 met the Hardy-Weinberg equilibrium (*p*\>0.05, χ^2^ value: 1.47; df: 2). The frequencies of *ICAM-1* SNPs rs3093030, rs5491 and rs5498 were also in Hardy-Weinberg equilibrium (*p*\>0.05, χ^2^ value: 0.00029; *p*\>0.05, χ^2^ value: 0.53 and *p*\>0.05, χ^2^ value: 0.97, respectively).

We found that there is no significantly different genotypic distributions in ICAM-1SNP rs5498 (A1548G) between Taiwanese patients with CAD and those without CAD. There were also no significant difference in rs5491 (K65M) and rs3093030 (C-286T). ICAM-1 SNP rs281432 was revealed as the only significant one of which the genotypes were distributed differently between the individuals with CAD and those without CAD. Using homozygotic wild genotype CC as a comparison reference in rs281432, the homozygotic mutant genotype GG exerted the decreased risk to develop CAD (*p*=0.025, Bonferroni test-corrected; OR: 0.40, 95% CI: 0.19-0.82). However, the heterozygous genotype CG could not show this decreased risk (*p*=1.000, Bonferroni test-corrected; OR: 1.10, 95% CI: 0.76-1.61). Only both mutant alleles GG in ICAM-1 SNP rs281432 could significantly protect the patients from CAD, using CC/CG as comparison references (*p*=0.006; OR: 0.38, 95% CI: 0.17-0.82; Table [3](#T3){ref-type="table"}).

Because rs5498 is in linkage disequilibrium with rs3093030based on Chinese HapMap data, we established the haplotypes of ICAM-1 SNPs rs5949 and rs3093030 in order and found four types of haplotypes, AC, AT, GC and GT. Thereafter, we associated these haplotypes with CAD. However, these haplotypes were not differently distributed between the Taiwanese subjects with CAD and those without CAD, while using haplotype AC as a comparison reference (Table [3](#T3){ref-type="table"}).

Multivariate analysis for the associations of the significant univariate clinical variables and ICAM-1 SNP rs281432 with CAD
----------------------------------------------------------------------------------------------------------------------------

We further used the multivariate method to analyze the associations of the significant univariate clinical variables, including male gender, aspirin use in the past 7 days, hypertension, diabetes mellitus, cardiac troponin I elevation, severe angina in the recent 24 hours and \> 3 risk factors, as well as ICAM-1 SNP rs281432 with CAD by logistic regression model. We found that the patients with both mutant alleles GG could decreased the risk of CAD (*p*=0.016; OR: 0.39, 95% CI: 0.18-0.84; Table [4](#T4){ref-type="table"}), using CC/CG as a reference (GG as a reference; the OR of CC/CG: 2.56, 95% CI: 1.19-5.56). Other factors which could affect the development of CAD included male gender (*p*=0.018; OR: 1.66, 95% CI: 1.09-2.51), aspirin use in the past 7 days (*p*=0.001; OR: 2.05, 95% CI: 1.33-3.14), hypertension (*p*\<0.001; OR: 2.15, 95% CI: 1.42-3.25), serum cardiac troponin I elevation (*p*\<0.001; OR: 2.18, 95% CI: 1.47-3.24) and severe angina in recent 24 hours (*p*=0.001; OR: 1.97, 95% CI: 1.31- 2.95).

The associations of demographic features and clinical variables with the only significant ICAM-1 SNP rs281432 in Taiwanese patients with CAD
--------------------------------------------------------------------------------------------------------------------------------------------

In the patients with CAD, we associated the demographic features and clinical variables with ICAM-1 SNPrs281432. These CAD patients were subdivided into the group with rs231432 GG and another group with CC/CG. We found that there are no significantly different demographic and clinical features among these two groups (Table [5](#T5){ref-type="table"}). This means that rs281432 is an independent factor that influences the development of CAD.

Discussion
==========

Our study revealed that only the subjects who have ICAM-1 SNP rs281432 homozygotic mutant GG significantly protect themselves from suffering CAD. The subjects with rs281432 CC/CG were more susceptible to CAD than those with GG. Other ICAM-1 SNPs, including rs5491, rs5498 and rs3093030, were not associated the development of CAD in Taiwanese patients who received elective coronary angiography due to positive noninvasive tests. The ICAM-1 gene was demonstrated to have functional activity and its genetic polymorphisms have been suggested to affect mRNA splicing patterns that modify cell-cell interactions and influence inflammatory response [@B22]. Additionally, the variants might have possible functional value in the etiology of atherosclerosis [@B15].

The association of rs281432 with CAD is not demonstrated up to date. However, its implication with disease has been reported. They showed that ICAM-1 gene SNP rs281432 (C8823G) confers susceptibility to the type 1 diabetes and is probably associated with diabetic nephropathy in Swedish Caucasians [@B13]. It was also revealed that ICAM-1 rs281432 may be applied as a factor to predict the clinical stage in oral squamous cell carcinoma patients [@B23].

The common ICAM-1 SNP being correlated with CAD is rs5498 (A1548G, K469E). K469E polymorphism of ICAM-1 that plays a role in atherosclerotic pathogenesis was demonstrated to be related to coronary slow flow [@B24]. This non-synonymous rs5498 locates three bases upstream of the splicing site in exon 6 and affects the splicing of ICAM-1 mRNA [@B22]. This splicing site produces either the full-length ICAM-1 (ICAM-1-L) or a truncated isoform (ICAM-1-S), which is soluble and has altered dimerization and signal transduction properties [@B7]. Inflammatory factors are the major mechanisms in the formation and progression of atherosclerosis [@B25]. One important inflammatory factor, ICAM-1, is a cell surface glycoprotein, which is released from endothelial cells, macrophages, and lymphocytes and may play an important role in the formation of atherosclerotic plaques because it mediates activation of endothelial cells, triggers inflammation, and causes transmigration and adhesion of leukocytes to vascular basal membranes [@B10]. Nevertheless, our study could not reveal an association of ICAM-1 rs5498 with CAD significantly. In agreement with this finding, no significant difference was also observed in the distribution of rs5498 genotypes in ICAM-1 gene between cases and controls by another study [@B26]. A number of SNPs may be silent with no direct effect on gene products. However, by virtue of linkage disequilibrium, such as rs5498 and rs3093030 in this study, which presents across the human genome, haplotypes can still be used as genetic markers to locate adjacent functional variants that contribute to disease. Although we further established the haplotypes of rs5498 and rs3093030, we still could not find an association of these haplotypes with CAD.

In addition to the relationship of ICAM-1 SNP rs281432 with CAD, our study found that male gender, aspirin use in the past 7 days, hypertension, diabetes mellitus, serum cardiac troponin I elevation, severe agina in recent 24 hours and more than 3 risk factors are important factors concerned with CAD using univariate analysis. Multivariate analysis further demonstrated that only male, aspirin use in the past 7 days, hypertension, cardiac troponin I elevation, severe angina in recent 24 hours and ICAM-1 rs281432 CC/CG increase the risk of the development of CAD. It has been demonstrated that the incidence of CAD was markedly lower in women \<60 years of age than in older women. After 60 years of age, the rate of CAD increased and reached the rate seen among men by the 8th decade of life [@B27].It was revealed that systolic-diastolic hypertension may increase the hazard ratio of 2.47 (95% CI: 2.16-2.82) for the development of CAD [@B28]. The hazard ratio of CAD has been showed up to 3.46 (95% CI: 1.59-7.54) in women with diabetes mellitus but not in male [@B29]. In contrast, our univariate analysis found that the risk of CAD is increased to 1.66 only in men with diabetes mellitus (*p*=0.033, 95% CI: 1.02-2.73), whereas this risk was not found in men and women with diabetes mellitus based on multivariate analysis (data not showed). Although continuous elevation of serum cholesterol may lead to its accumulation within the artery wall, subsequent inflammatory response, and formation of atherosclerotic plaques [@B5], this study did not show the difference of the serum cholesterol concentrations between the patients with CAD and without CAD. Another important biomarker which predicted CAD in this study was elevated serum troponin I. Serum cardiac troponin levels have been purposed to be essential for diagnostic assessment and risk prediction in patients with symptoms of unstable coronary artery disease [@B30]. Cardiac Troponin I even reflects the myocardial injury because it is a component of the contractile apparatus of myocardial cells, which is expressed almost exclusively in the heart [@B31].

One limitation of the study is that the participants were male and female subjects who received elective coronary angiography because of positive noninvasive tests. Based on the ethical guidelines, it was impossible to do routine coronary angiography for the healthy individuals who were regarded as controls. Therefore, this may affect the types of ICAM-1 SNP which were related to the development of CAD. However, our findings that ICAM-1 SNP rs281432 affected the development of CAD are especially recommended applicable to the Taiwanese subjects who have heart problems and seek for medical help because of positive noninvasive tests. Another limitation is that the cohort is fairly small for studying CAD. It only included 339 subjects with CAD and 186 without CAD. It is necessary that more individuals are recruited to associate the ICAM-1 SNPs with CAD susceptibility in Taiwanese subjects in the future. Furthermore, the level of vascular ICAM-1 gene of CAD patients versus non-CAD control to see how SNP rs281432, in particular, that carrying homozygotic GG mutation, affect ICAM-1 in atherosclerosis is worth for further investigation, which will be included in our future work.

In this study, we also related the ICAM-1 SNP rs281432 to the demographic features and clinical variables in the patients with CAD. We found that there is no association between these factors and rs281432. This implies that ICAM-1 SNP rs281432 is an independent factor to predict the development of CAD. To our knowledge, this study is the first comprehensive one to associate ICAM-1 SNP rs231432 (C8823G) with CAD in Taiwanese subjects. Moreover, we found that ICAM-1 SNP rs281432 homozygotic mutant GG can reduce the susceptibility to the CAD.

###### 

Demographic features of patients with coronary artery disease (CAD) and those without CAD.

  ------------------------------------------------------------------------------------------
  Demographic features                            Positive CAD\   Negative CAD\   *p*
                                                  (N= 339)        (N= 186)        
  ----------------------------------------------- --------------- --------------- ----------
  **Gender**                                                                      0.004^a^

  Male                                            251             115             

  female                                          88              71              

  **Age (years; mean ±SD)**                       65.6± 11.1      66.1 ± 12.0     0.659

  **Body length (cm; mean ±SD)**                  161.8 ± 8.5     160.6 ± 8.8     0.132

  **Body weight (kg; mean ±SD)**                  66.9 ± 12.4     65.0 ± 13.2     0.106

  **Body mass index (kg/m^2^; mean ±SD)**         25.5 ± 4.4      25.1 ± 3.8      0.238

  **Systolic blood pressure (mmHg; mean ±SD)**    132.5 ± 21.5    129.9 ± 19.7    0.172

  **Diastolic blood pressure (mmHg; mean ±SD)**   79.1 ± 15.7     77.2 ± 14.4     0.195
  ------------------------------------------------------------------------------------------

Statistical analysis: Student *t* test or chi-square test

^a^*p*\<0.05

SD: standard deviation

###### 

Association of clinical variables with coronary artery disease (CAD)

  -----------------------------------------------------------------------------------------------------------------------
  Clinical parameters                     Positive CAD (N= 339)   Negative CAD (N= 186)   *p*^a^       Odds ratio\
                                                                                                       (95% CI)
  --------------------------------------- ----------------------- ----------------------- ------------ ------------------
  **Gender**                                                                              0.004^a^     

  female^b^                               88                      71                                   1.00

  male                                    251                     115                                  1.76 (1.18-2.63)

  **Age (years)**                                                                         0.335        

  ≤ 65^b^                                 157                     78                                   1.00

  \> 65                                   182                     108                                  0.84 (0.57-1.22)

  **Family history**                                                                      0.818        

  negative^b^                             269                     146                                  1.00

  positive                                70                      40                                   0.95 (0.60-1.51)

  **Smoker**                                                                              0.160        

  non-active^b^                           190                     116                                  1.00

  active                                  149                     70                                   1.30 (0.89-1.91)

  **Aspirin use in the past 7 days**                                                      0.001^a^     

  negative^b^                             194                     139                                  1.00

  positive                                128                     46                                   1.99 (1.31-3.05)

  **Cholesterol (mg/dL)**                                                                 0.803        

  ≤ 200^b^                                199                     106                                  1.00

  \> 200                                  106                     77                                   0.73 (0.49-1.09)

  **Hypertension**                                                                        \<0.001^a^   

  negative^b^                             86                      75                                   1.00

  positive                                253                     111                                  1.99 (1.33-2.96)

  **Diabetes mellitus**                                                                   0.034^a^     

  negative^b^                             194                     124                                  1.00

  positive                                145                     62                                   1.49 (1.01-2.21)

  **Cardiac troponin I elevation**                                                        \<0.001^a^   

  negative^b^                             136                     112                                  1.00

  positive                                203                     74                                   2.26 (1.54-3.31)

  **Recent severe angina (\<24 hours)**                                                   \<0.001^a^   

  negative^b^                             98                      83                                   1.00

  positive                                239                     103                                  1.97 (1.33-2.90)

  **Risk factors (\>3)**                                                                  0.017^a^     

  negative^b^                             140                     97                                   1.00

  positive                                199                     89                                   1.55 (1.06-2.26)

  **Stroke**                                                                              0.470        

  negative^b^                             288                     151                                  1.00

  positive                                34                      22                                   0.81 (0.44-1.51)
  -----------------------------------------------------------------------------------------------------------------------

Statistical analysis: Chi-square test

^a^*p*\<0.05

^b^Used as a reference for comparison to evaluate the odds ratio of another parameter.

###### 

Genotype distributions of the single nucleotide polymorphisms (SNPs) and haplotypes of the intercellular adhesion molecule-1 (ICAM-1) gene in patients with coronary artery disease (CAD) and those without CAD

  -----------------------------------------------------------------------------------------------------------
  ICAM1 SNPs                                    Positive CAD\   Negative CAD\   *p*^a^     Odds ratio\
                                                (N= 339)        (N= 186)                   (95% CI)
  --------------------------------------------- --------------- --------------- ---------- ------------------
  **rs5491**                                                                               

  AA^b^                                         300             167             0.556      1.00

  AT                                            37              19                         1.08 (0.60-1.95)

  TT                                            2               0                          \-\-\--

  AA^b^                                         300             167                        1.00

  AT/TT                                         39              19                         1.14 (0.62-2.16)

  AA/AT^b^                                      337             186                        1.00

  TT                                            2               0                          \-\-\--

  **rs5498**                                                                               

  AA^b^                                         177             94              0.891      1.00

  AG                                            143             80                         0.95 (0.64-1.40)

  GG                                            19              12                         0.84 (0.39-1.81)

  AA^b^                                         177             94              0.713      1.00

  AG/GG                                         162             92                         0.94 (0.64-1.36)

  AA/AG^b^                                      320             174             0.694      1.00

  GG                                            19              12                         0.86 (0.39-1.99)

  **rs281432**                                                                             

  CC^b^                                         179             96              0.020^a^   1.00

  CG                                            146             71                         1.10 (0.76-1.61)

  GG                                            14              19                         0.40 (0.19-0.82)

  CC^b^                                         179             96              0.794      1.00

  CG/GG                                         160             90                         0.95 (0.66-1.39)

  CC/CG^b^                                      325             167             0.006      1.00

  GG                                            14              19                         0.38 (0.17-0.82)

  **rs3093030**                                                                            

  CC^b^                                         222             113             0.538      1.00

  CT                                            101             64                         0.80 (0.55-1.18)

  TT                                            16              9                          0.90 (0.39-2.11)

  CC^b^                                         222             113             0.280      1.00

  CT/TT                                         117             73                         0.82 (0.55-1.20)

  CC/CT^b^                                      323             177             0.951      1.00

  TT                                            16              9                          0.97 (0.40-2.56)

  Haplotypes of rs5498 and rs3093030 (N=1050)                                   0.671      

  AC^b^                                         492             263                        1.00

  AT                                            53              27                         1.50 (0.65-1.71)

  GC                                            5               5                          0.54 (0.12-2.35)

  GT                                            128             77                         0.89 (0.65-1.22)
  -----------------------------------------------------------------------------------------------------------

Statistical analysis: Chi-square or Fisher exact tests; multiple comparisons within 3 genotypes among each SNP and 4 haplotypes were adjusted using simple logistic regression model for the calculation of odds ratios and their 95% confidence intervals.

^a^*p*\<0.05

^b^Used as a reference for comparisons to evaluate the odds ratios of other genotypes.

###### 

Multivariate analysis for the associations of intercellular adhesion molecule-1 (ICAM-1) single nucleotide polymorphisms and clinical characteristics with coronary artery disease (CAD)

  ---------------------------------------------------------------------------------------------------------------------------
  Clinical parameters                     Positive CAD (N= 339)   Negative CAD (N= 186)   *P*^a^       Adjusted odds ratio\
                                                                                                       (95% CI)
  --------------------------------------- ----------------------- ----------------------- ------------ ----------------------
  **Gender**                                                                              0.018^a^     

  female^b^                               88                      71                                   1.66

  male                                    251                     115                                  (1.09-2.51)

  **Aspirin use in the past 7 days**                                                      0.001^a^     

  negative^b^                             194                     139                                  1.00

  positive                                128                     46                                   2.05 (1.33-3.14)

  **Hypertension**                                                                        \<0.001^a^   

  negative^b^                             86                      75                                   1.00

  positive                                253                     111                                  2.15 (1.42-3.25)

  **Cardiac troponin I elevation**                                                        \<0.001^a^   

  negative^b^                             136                     112                                  1.00

  positive                                203                     74                                   2.18 (1.47-3.24)

  **Recent severe angina (\<24 hours)**                                                   0.001^a^     

  negative^b^                             98                      83                                   1.00

  positive                                239                     103                                  1.97 (1.31-2.95)

  **rs281432**                                                                            0.016^a^     

  CC/CG^b^                                325                     167                                  1.00

  GG                                      14                      19                                   0.39 (0.18-0.84)
  ---------------------------------------------------------------------------------------------------------------------------

Statistical analysis: logistic regression model

^a^*p*\<0.05

^b^Used as a reference for comparison to evaluate the odds ratio of another variable.

###### 

The comparisons of demographic features and clinical variables between the single nucleotide polymorphism of intercellular adhesion molecule-1rs281432 GG and CC/CG groups in patients with coronary artery disease (CAD)

  -------------------------------------------------------------------------------------------------
  Clinical parameters^a^                  rs281432 GG   rs281432 CC/CG   *P*     Odds ratio\
                                                                                 (95% CI)
  --------------------------------------- ------------- ---------------- ------- ------------------
  **Gender**                                                             0.336   

  female^b^                               7             152                      1.00

  male                                    24            342                      1.52 (0.62-4.28)

  **Age (years)**                                                        0.125   

  ≤ 65^b^                                 18            217                      1.00

  \> 65                                   13            277                      0.57 (0.25-1.25)

  **Family history**                                                     0.822   

  negative^b^                             25            390                      1.00

  positive                                6             104                      0.90 (0.29-2.33)

  **Smoker**                                                             0.688   

  non-active^b^                           17            289                      1.00

  active                                  14            205                      1.16 (0.52-2.57)

  **Aspirin use in the past 7 days**                                     0.285   

  negative^b^                             21            312                      1.00

  positive                                7             167                      0.62 (0.22-1.56)

  **Cholesterol**                                                        0.289   

  ≤ 200^b^                                21            284                      1.00

  \> 200                                  10            205                      0.66 (0.27-1.50)

  **Hypertension**                                                       0.317   

  negative^b^                             12            149                      1.00

  positive                                19            345                      0.68 (0.31-1.59)

  **Diabetes mellitus**                                                  0.501   

  negative^b^                             17            301                      1.00

  positive                                14            193                      1.28 (0.57-2.84)

  **Cardiac troponin I elevation**                                       0.177   

  negative^b^                             11            237                      1.00

  positive                                20            257                      1.68 (0.75-3.96)

  **Recent severe angina (\<24 hours)**                                  0.203   

  negative^b^                             14            167                      1.00

  positive                                17            325                      0.62 (0.28-1.41)

  **Risk factors (\>3)**                                                 0.998   

  negative^b^                             14            223                      1.00

  positive                                17            271                      1.00 (0.45-2.24)

  **Stroke**                                                             0.183   

  negative^b^                             27            412                      1.00

  positive                                1             55                       0.28 (0.01-1.76)
  -------------------------------------------------------------------------------------------------

Statistical analysis: Chi-square or Fisher exact tests

^a^Some clinical data could not be collected from the patients due to incomplete medical charts or records.

^b^Used as a reference for comparison to evaluate the odds ratio of another genotype.

[^1]: Competing Interests: The authors have declared that no competing interest exists.
